These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23759353)

  • 1. Pharmacovigilance and use of online health information.
    Masoni M; Guelfi MR; Conti A; Gensini GF
    Trends Pharmacol Sci; 2013 Jul; 34(7):357-8. PubMed ID: 23759353
    [No Abstract]   [Full Text] [Related]  

  • 2. e-Phytovigilance for misleading herbal information.
    Maggini V; Gallo E; Vannacci A; Gori L; Mugelli A; Firenzuoli F
    Trends Pharmacol Sci; 2013 Nov; 34(11):594-5. PubMed ID: 24139611
    [No Abstract]   [Full Text] [Related]  

  • 3. Encouraging spontaneous reporting of adverse effects.
    Prescrire Int; 2015 Feb; 24(157):53. PubMed ID: 25802925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The reorganisation of European pharmacovigilance. Part 2. From spontaneous reports to agency reviews and decisions.
    Prescrire Int; 2015 Feb; 24(157):50-4. PubMed ID: 25802924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Asian Pharmacoepidemiology Network (AsPEN): promoting multi-national collaboration for pharmacoepidemiologic research in Asia.
    ; Andersen M; Bergman U; Choi NK; Gerhard T; Huang C; Jalbert J; Kimura M; Kimura T; Kubota K; Lai EC; Ooba N; Park BJ; Pratt N; Roughead EE; Sato T; Setoguchi S; Shin JY; Sundström A; Yang YH
    Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):700-4. PubMed ID: 23653370
    [No Abstract]   [Full Text] [Related]  

  • 6. Free access to pharmacovigilance data.
    Prescrire Int; 2006 Aug; 15(84):138. PubMed ID: 16991216
    [No Abstract]   [Full Text] [Related]  

  • 7. [Direct reporting by patients of adverse drug reactions in Spain].
    Esther Salgueiro M; Jimeno FJ; Aguirre C; García M; Ordóñez L; Manso G
    Farm Hosp; 2013; 37(1):65-71. PubMed ID: 23461502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ISoP CommSIG for Improving Medicinal Product Risk Communication: A New Special Interest Group of the International Society of Pharmacovigilance.
    Bahri P; Dodoo AN; Edwards BD; Edwards IR; Fermont I; Hagemann U; Hartigan-Go K; Hugman B; Mol PG
    Drug Saf; 2015 Jul; 38(7):621-7. PubMed ID: 26032946
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyberpharmacovigilance: What is the usefulness of the social networks in pharmacovigilance?
    Bagheri H; Lacroix I; Guitton E; Damase-Michel C; Montastruc JL
    Therapie; 2016 Apr; 71(2):235-9. PubMed ID: 27080844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reactions in neonates: could we be documenting more?
    Hawcutt DB; O'Connor O; Turner MA
    Expert Rev Clin Pharmacol; 2014 Nov; 7(6):807-20. PubMed ID: 25225053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacovigilance in Europe.
    Johnson CL; Hutchinson JA
    Transplantation; 2015 Aug; 99(8):1542-3. PubMed ID: 26308299
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacogenovigilance: a pharmacogenomics pharmacovigilance program.
    Awada Z; Zgheib NK
    Pharmacogenomics; 2014 Apr; 15(6):845-56. PubMed ID: 24897290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug safety. Why and how? "All drugs are dangerous, some are also useful"].
    Moore N
    Prog Urol; 2013 Nov; 23(15):1213-5. PubMed ID: 24183077
    [No Abstract]   [Full Text] [Related]  

  • 14. Knowledge, attitude and practices associated with adverse drug reaction reporting amongst doctors in a teaching hospital.
    Chopra D; Wardhan N; Rehan HS
    Int J Risk Saf Med; 2011; 23(4):227-32. PubMed ID: 22156087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analysis of Vigimed, a global e-mail system for the exchange of pharmacovigilance information.
    Johansson K; Olsson S; Hellman B; Meyboom RH
    Drug Saf; 2007; 30(10):883-9. PubMed ID: 17867725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cross-sectional study of adverse drug reactions reporting among doctors of a private medical college in Bihar, India.
    Panja B; Bhowmick S; Chowrasia VR; Bhattacharya S; Chatterjee RN; Sen A; Sarkar M; Ram AK; Mukherjee PK
    Indian J Pharmacol; 2015; 47(1):126-7. PubMed ID: 25821329
    [No Abstract]   [Full Text] [Related]  

  • 17. The EU-ADR Web Platform: delivering advanced pharmacovigilance tools.
    Oliveira JL; Lopes P; Nunes T; Campos D; Boyer S; Ahlberg E; van Mulligen EM; Kors JA; Singh B; Furlong LI; Sanz F; Bauer-Mehren A; Carrascosa MC; Mestres J; Avillach P; Diallo G; Díaz Acedo C; van der Lei J
    Pharmacoepidemiol Drug Saf; 2013 May; 22(5):459-67. PubMed ID: 23208789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse drug reaction monitoring and the Internet: evaluation of the use of the Internet by French Pharmacovigilance Centres and a non-exhaustive survey of websites of interest for collecting information about adverse drug reaction.
    Morel P; Vandel B
    Therapie; 1999; 54(5):525-32. PubMed ID: 10667084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacovigilance amongst patent medicine vendors (PMVs) in Ekiti state, Nigeria.
    Awodele O; Adeniran A; Awodele DF
    Int J Risk Saf Med; 2012; 24(2):65-72. PubMed ID: 22751188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selected national pharmacovigilance websites: an analysis of contents.
    Barker CI; Talbot JC; Aronson JK
    Drug Saf; 2012 Feb; 35(2):141-8. PubMed ID: 22168572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.